Bioelectric Medicine Market

IMARC Group, a leading market research company, has recently releases report titled “Bioelectric Medicine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” The global bioelectric medicine market size reached US$ 21.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 30.2 Billion by 2028, exhibiting a growth rate (CAGR) of 5.9% during 2023-2028.

What is Bioelectric Medicine Market?

Bioelectric medicine, also referred to as electroceuticals, involves the use of electrical impulses and signaling in the nervous system for medical purposes. It integrates disciplines like neuroscience, molecular medicine, and bioengineering to develop nerve-stimulating technologies that influence biological processes. Within the field of bioelectric medicine, there are various devices and treatments available, including pain relief mechanisms, cardiac pacemakers, cochlear and retinal implants, spinal cord stimulators, and implantable defibrillators. These devices often consist of small electronic implants capable of diagnosing and treating chronic diseases like inflammatory bowel disease, cancer, rheumatoid arthritis, obesity, diabetes, asthma, paralysis, and cardiovascular diseases (CVDs). Bioelectric medicine employs both non-invasive and invasive approaches to address a wide range of conditions and disorders.

Request a free sample brochure: https://www.imarcgroup.com/bioelectric-medicine-market/requestsample

Bioelectric Medicine Market Trends and Drivers: 

The increasing incidences of neurological and cardiovascular disorders and the expanding geriatric population are primarily driving the bioelectric medicine market. Additionally, the growing prevalence of arrhythmia that involves the use of cardiac pacemakers and implantable cardioverter-defibrillators to treat the ailment is further catalyzing the market growth. Besides this, the escalating demand for deep brain stimulators, on account of the rising cases of lifestyle-induced disorders, such as depression and obesity, and Parkinson's disease, is acting as another significant growth-inducing factor. Moreover, leading manufacturers are developing smart products that aid in the early diagnosis and detection of cardiac arrhythmias and cater unmet needs of consumers, which is positively influencing the global market. Apart from this, the introduction of new therapies and electroceuticals and extensive R&D activities are also propelling the market growth. Furthermore, continuous advancements in healthcare infrastructures and the inflating expenditure capacities of individuals are anticipated to fuel the bioelectric medicine market over the forecasted period.

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Type:

• Implantable Electroceutical Devices

• Non-Invasive Electroceutical Devices

Breakup by Product:

• Implantable Cardioverter Defibrillators

• Cardiac Pacemakers

• Cochlear Implants

• Spinal Cord Stimulators

• Deep Brain Stimulators

• Transcutaneous Electrical Nerve Stimulators

• Sacral Nerve Stimulators

• Vagus Nerve Stimulators

• Others

Breakup by Application:

• Arrhythmia

• Pain Management

• Sensorineural Hearing Loss

• Parkinson’s Disease

• Tremor

• Depression

• Treatment-Resistant Depression

• Epilepsy

• Urinary and Fecal Incontinence

• Others

Breakup by End Use:

• Hospitals

• Research Institutes

• Individual Users

• Others

Click here to view detailed information with table of content: https://www.imarcgroup.com/bioelectric-medicine-market

By Geography:

• North America: (United States, Canada)

• Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)

• Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)

• Latin America: (Brazil, Mexico, Others)

• Middle East and Africa

Who are the key players operating in the industry?

• Abbott Laboratories

• Biotronik SE & Co KG

• Boston Scientific Corporation

• Cochlear Limited

• electroCore Inc.

• LivaNova PLC

• MED-EL Medical Electronics

• Medtronic plc and Sonova Holding AG.

 About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800